Found: 12
Select item for more details and to access through your institution.
Increased Plasma Concentrations of Unbound SN-38, the Active Metabolite of Irinotecan, in Cancer Patients with Severe Renal Failure.
- Published in:
- Pharmaceutical Research, 2016, v. 33, n. 2, p. 269, doi. 10.1007/s11095-015-1785-0
- By:
- Publication type:
- Article
Re: UGT1A1*28 Genotype and Irinotecan-Induced Neutropenia: Dose Matters.
- Published in:
- 2008
- By:
- Publication type:
- Letter
Regimen Selection for First-line FOLFIRI and FOLFOX Based on UGT1A1 Genotype and Physical Background is Feasible in Japanese Patients with Advanced Colorectal Cancer.
- Published in:
- Japanese Journal of Clinical Oncology, 2011, v. 41, n. 5, p. 617, doi. 10.1093/jjco/hyr010
- By:
- Publication type:
- Article
Phase I/II Study of FOLFIRI in Japanese Patients with Advanced Colorectal Cancer.
- Published in:
- Japanese Journal of Clinical Oncology, 2011, v. 41, n. 2, p. 204, doi. 10.1093/jjco/hyq197
- By:
- Publication type:
- Article
Clinical and Economic Evaluation of First-line Therapy with FOLFIRI or Modified FOLFOX6 for Metastatic Colorectal Cancer.
- Published in:
- Japanese Journal of Clinical Oncology, 2010, v. 40, n. 7, p. 634, doi. 10.1093/jjco/hyq029
- By:
- Publication type:
- Article
A clinical pharmacokinetic microdosing study of docetaxel with Japanese patients with cancer.
- Published in:
- 2015
- By:
- Publication type:
- journal article
No pharmacokinetic alteration of docetaxel following coadministration of aprepitant 3 h before docetaxel infusion.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2014, v. 74, n. 3, p. 539, doi. 10.1007/s00280-014-2528-3
- By:
- Publication type:
- Article
UGT1A1*1/*28 and *1/ *6 genotypes have no effects on the efficacy and toxicity of FOLFIRI in Japanese patients with advanced colorectal cancer.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2011, v. 68, n. 2, p. 279, doi. 10.1007/s00280-010-1485-8
- By:
- Publication type:
- Article
Association of UGT2B7 and ABCB1 genotypes with morphine-induced adverse drug reactions in Japanese patients with cancer.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2010, v. 65, n. 2, p. 251, doi. 10.1007/s00280-009-1029-2
- By:
- Publication type:
- Article
A Phase I Study of Infusional 5-Fluorouracil, Leucovorin, Oxaliplatin and Irinotecan in Japanese Patients with Advanced Colorectal Cancer Who Harbor UGT1A1*1/*1,*1/*6 or *1/*28.
- Published in:
- Oncology, 2012, v. 82, n. 4, p. 242, doi. 10.1159/000337225
- By:
- Publication type:
- Article
CYP2A6 and the plasma level of 5-chloro-2, 4-dihydroxypyridine are determinants of the pharmacokinetic variability of tegafur and 5-fluorouracil, respectively, in Japanese patients with cancer given S-1.
- Published in:
- Cancer Science, 2008, v. 99, n. 5, p. 1049, doi. 10.1111/j.1349-7006.2008.00773.x
- By:
- Publication type:
- Article
Direct Inhibition and Down-regulation by Uremic Plasma Components of Hepatic Uptake Transporter for SN-38, an Active Metabolite of Irinotecan, in Humans.
- Published in:
- Pharmaceutical Research, 2014, v. 31, n. 1, p. 204, doi. 10.1007/s11095-013-1153-x
- By:
- Publication type:
- Article